NASDAQ: SYRE · Health Care / Biotechnology: Pharmaceutical Preparations

Spyre Therapeutics Inc.

How Spyre Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$10.3B

Price

$98.96

P/E

-48.7

EPS (TTM)

$-2.03

1-year return

315.3%

Dividend yield

0.0%

52-week range

$23.47–$98.96

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources